| Product Code: ETC8892908 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Portugal continued to import pregabalin primarily from China, Switzerland, Belgium, Italy, and India. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained at a moderate level. The compound annual growth rate (CAGR) from 2020 to 2024 was 0.74%, indicating steady growth in imports. Additionally, the growth rate from 2023 to 2024 saw a notable increase of 6.56%, suggesting a potential rise in demand for pregabalin in Portugal. These trends highlight the significance of these importing countries in supplying pregabalin to the Portuguese market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Pregabalin Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Pregabalin Market - Industry Life Cycle |
3.4 Portugal Pregabalin Market - Porter's Five Forces |
3.5 Portugal Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Portugal Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Portugal Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Portugal Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuropathic pain conditions in Portugal |
4.2.2 Growing awareness about the benefits of pregabalin in managing chronic pain |
4.2.3 Rising geriatric population leading to higher demand for pain management medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in Portugal |
4.3.2 Competition from alternative pain management therapies |
4.3.3 Potential side effects and safety concerns associated with pregabalin use |
5 Portugal Pregabalin Market Trends |
6 Portugal Pregabalin Market, By Types |
6.1 Portugal Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Portugal Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Portugal Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Portugal Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 Portugal Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 Portugal Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Portugal Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Portugal Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 Portugal Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 Portugal Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Portugal Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Portugal Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Portugal Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Portugal Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 Portugal Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 Portugal Pregabalin Market Import-Export Trade Statistics |
7.1 Portugal Pregabalin Market Export to Major Countries |
7.2 Portugal Pregabalin Market Imports from Major Countries |
8 Portugal Pregabalin Market Key Performance Indicators |
8.1 Number of prescriptions for pregabalin in Portugal |
8.2 Patient adherence rate to pregabalin treatment |
8.3 Number of clinical trials and research studies on pregabalin efficacy and safety |
9 Portugal Pregabalin Market - Opportunity Assessment |
9.1 Portugal Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Portugal Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Portugal Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Portugal Pregabalin Market - Competitive Landscape |
10.1 Portugal Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 Portugal Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here